Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
about
Synthesis of Gold Nanoparticles with Buffer-Dependent Variations of Size and Morphology in Biological BuffersHost-guest supramolecular nanosystems for cancer diagnostics and therapeutics.Gold nanoparticle conjugates: recent advances toward clinical applications.Gold nanoparticles for photothermally controlled drug release.Nanoparticles functionalized with supramolecular host-guest systems for nanomedicine and healthcare.Inorganic nanoparticles engineered to attack bacteria.Thermoresponsive cyclodextrins with switchable inclusion abilities
P2860
Q36547550-D753995A-0C48-43D6-86FC-2EA3E554B301Q38139328-CD655EFC-EFF8-49F3-A8CD-89090089F4A9Q38190087-49C682F0-E1EC-470F-A8E6-02FD05CD784FQ38262549-070EB1DE-53B5-42AB-B303-031B3561E4D7Q38495100-8C04E4B9-0CD2-417E-B398-C54CC73C97BCQ38550551-D02C07A3-3B7B-43A5-BC0E-EDE469AEE507Q57367364-1D66618B-0DA4-4947-92C5-BBEC8C83CC19
P2860
Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
description
im Januar 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2011
@uk
name
Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
@en
Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
@nl
type
label
Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
@en
Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
@nl
prefLabel
Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
@en
Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
@nl
P2093
P2860
P356
P1476
Polyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
@en
P2093
Mahdieh Kalantari
Raziyeh Yadollahi Farsi
Reza Sadeghi Sarabi
P2860
P356
10.1039/C1JM12412A
P577
2011-01-01T00:00:00Z